IK Investment Partners to acquire Ellab
IK Investment Partners (“IK”) is pleased to announce that the IK VIII Fund has reached an agreement to acquire Ellab A/S (“Ellab” or “the Company”), a leading manufacturer of thermal validation solutions, primarily used for validation for food and pharmaceutical industries, from a group of private investors. Financial terms of the transaction are not disclosed.
Founded in 1949, Ellab is a leading global supplier of solutions for measuring, recording, monitoring and validating critical parameters of thermal processing, selling its products in over 65 countries across the globe. The Company offers a wide product range of high-precision systems for temperature, pressure and humidity monitoring and validation based on either data loggers or thermocouple based wired instruments. Ellab’s products are used by the pharmaceutical and food industry as well as hospitals, where accurate and complete documentation is essential.
“Ellab contributes to increase consumer safety, and we take pride in quality. We are looking forward to partnering with IK Investment Partners to support our next stage of growth and innovation. With their industry experience and financial resources, we are confident that they are the perfect partners to further our success,” says Peter Krogh, CEO of Ellab.
“With its accurate, versatile and reliable solutions, Ellab holds a unique market position. The Company is known worldwide as a leading manufacturer of complete instrumentation, software, probes, fittings and accessories for thermal validation solutions, and we believe there are significant growth opportunities ahead. Ellab has a strong culture of innovation and collaboration, and we are looking forward to support Peter and his team to continuing to develop thermal validation systems and services of world class standards,” says Alireza Etemad, Partner at IK Investment Partners.
Rothschild & Co acted as financial advisor and Bruun Hjejle as legal advisor to IK Investment Partners.
For further questions: